Based on limited published evidence, TMED7-TICAM2 readthrough is proposed to inhibit LPS-TLR4 signaling at late endosomes by disrupting the interaction between TICAM2 isoform 1 and TICAM1, potentially facilitating TLR4 degradation. The gene has been identified as a cis-associated NF-κB pathway regulator whose expression score correlates with transformation of follicular lymphoma to aggressive disease 1, suggesting involvement in B-cell survival and activation pathways.